The human paraoxonase Gln-Arg192 (Q/R) polymorphism in Turkish patients with coronary artery disease
- 1 June 2000
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 74 (1) , 33-37
- https://doi.org/10.1016/s0167-5273(00)00242-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Gln-Arg192 Polymorphism of Human Paraoxonase Gene Is Not Associated With Coronary Artery Disease in Italian PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- A 192 Arg Variant of the Human Paraoxonase (HUMPONA) Gene Polymorphism Is Associated With an Increased Risk for Coronary Artery Disease in the JapaneseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxonBritish Journal of Pharmacology, 1997
- Genetic Polymorphism of Paraoxonase and the Risk of Coronary Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.Journal of Clinical Investigation, 1996
- A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease.Journal of Clinical Investigation, 1995
- Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.Journal of Clinical Investigation, 1995
- Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetesThe Lancet, 1995
- The molecular basis of the human serum paraoxonase activity polymorphismNature Genetics, 1993
- Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoproteinFEBS Letters, 1991